OP-EHEA191011_online 2313..2340 Page 1 Low-density lipoproteins cause atherosclerotic
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …

Abstract Purpose of the Review High-density lipoproteins (HDL) are responsible for the
transport in plasma of a large fraction of circulating lipids, in part from tissue mobilization …

Epidemiologically, high-density lipoprotein (HDL) cholesterol levels have been inversely
associated to cardiovascular (CV) events, although a Mendelian Randomisation Study had …

Despite the ability of current efficacious low‐density lipoprotein‐cholesterol–lowering
therapies to reduce total cardiovascular disease (CVD) risks, CVD still poses major risks for …

Background and Aims. Apolipoprotein A‐I (ApoA‐I), the main component of high‐density
lipoprotein (HDL), not only promotes reverse cholesterol transport (RCT) in atherosclerosis …

Background Increasing evidence showed that carbamylated lipoprotein accelerated
atherosclerosis. However, whether such modification of high-density lipoprotein (HDL) …

Accumulating evidence suggests that hypertriglyceridemia is an independent risk factor for
endothelial dysfunction. Triglycerides should be considered more seriously as a future target …

Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder that elevates low-
density lipoprotein cholesterol and increases the risk of premature atherosclerotic …

Abstract Background Apolipoprotein (Apo) AI is a major protein component of high-density
lipoprotein (HDL) that causes cholesterol efflux from peripheral cells through ATP-binding …

The lymphatic system is a drainage network composed of capillaries, precollector and
collector vessels, and lymph nodes. The blind-ended lymphatic capillaries are tiny, thin-wall …